
CJC-1295 No DAC
10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.
Free U.S. shipping $175+

Human menopausal gonadotropin is a gonadotropin preparation containing both follicle-stimulating hormone and luteinizing hormone activity.
Because it supplies two gonadotropin activities together, it is used in laboratory research examining combined FSH and LH receptor signaling in reproductive endocrine models, where separating the two inputs is not the object of the experiment.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
HMG is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.

10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.

5/5 mg
Combined GHRH analog and secretagogue receptor agonist preparation for dual-input pituitary research.

5 mg
GHRH analog with Drug Affinity Complex modification for extended-duration receptor research.

10 mg
Second-generation growth hormone releasing peptide studied as a ghrelin receptor agonist reference.